Dr. Guy Young 3440 Torrance Boulevard, Torrance, CA 90503

Dr. Guy Young is a renowned institution located at 3440 Torrance Boulevard, Torrance, California, United States. Specializing in pediatric hematology/oncology, Dr. Guy Young completed his medical training at prestigious institutions such as Schneider Children's Hospital-Long Island Jewish Medical Center and Children's National Medical Center in Washington, DC. With a focus on state-of-the-art therapies for children with bleeding or clotting disorders, the institution conducts groundbreaking research in areas such as hemophilia and thrombosis.

Dr. Guy Young's team is dedicated to improving the management of patients with hemophilia and thrombosis by testing novel therapies and assessing patient responses. Through collaborations with industry partners, the institution is testing new compounds to enhance patient outcomes in hemophilia. Additionally, they are evaluating drugs approved for adult use for their safety and efficacy in pediatric patients with thrombosis.

One of the institution's key research tools is the thromboelastograph, which allows them to predict bleeding or clotting events in patients with a high degree of accuracy. By identifying patients at risk for thrombosis, they can intervene with prophylactic medications to prevent clot formation. This innovative approach has led to numerous publications and grants from prestigious organizations such as the National Institutes of Health (NIH) and the Centers for Disease Control and Prevention (CDC).

Dr. Guy Young's research has had a global impact, influencing clinical practice and changing the approach to managing hemophilia in children. By introducing novel regimens and demonstrating the utility of the thromboelastograph, the institution has helped improve patient outcomes and advance the field of pediatric hematology/oncology.

With a focus on offering patients the most cutting-edge treatments and technologies available, Dr. Guy Young continues to push the boundaries of research in pediatric hematology/oncology. Through ongoing funding from various sources, including federal grants and private foundations, the institution remains at the forefront of innovative research in the field.